Chennai

Russia became the first country in the world to register a vaccine against the novel coronavirus. Named 'Sputnik V', the vaccine's Phase III trials are still underway.

According to the recent report by The Moscow Times, 1 in 7 trial volunteers have complained of side effects after consuming Sputnik V vaccine. The side effects include muscle pain and weakness. Approximately 14 per cent of the trial volunteers have complained of these predicted side effects.

Amidst this, Russian Direct Investment Fund (RDIF) has agreed to supply 100 million doses of Sputnik V vaccine to India's drug firm Dr Reddy's laboratories. It is to be noted that India is one of the largest consumer of Russia's arms and oil.

It is reported that the distribution of Sputnik V vaccine in Russia will begin in late 2020, after the late-stage trials.

Visit news.dtnext.in to explore our interactive epaper!

Download the DT Next app for more exciting features!

Click here for iOS

Click here for Android